Atrium Therapeutics, Inc.
RNA • Biotechnology
$8.06
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 32%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$137.87M
Growth
—
Cash Flow
—
Trend
Limited data
Evidence
Manageable debt level · 0.02Healthy liquidity · 6.53Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$8.06
Change0.00%
Shares Out17.11M
Market Cap$137.87M
Enterprise Value$-127.30M
52W Range11.13 - 16.77
Beta0.37
P/B0.59
Gross Margin100.00%
Oper. Margin-4.13%
Profit Margin-4.12%
Debt/Eq0.02
Price$8.06
Change0.00%
Shares Out17.11M
Market Cap$137.87M
Enterprise Value$-127.30M
52W Range11.13 - 16.77
Beta0.37
P/B0.59
Gross Margin100.00%
Oper. Margin-4.13%
Profit Margin-4.12%
Debt/Eq0.02
Current Ratio6.53
Quick Ratio6.53
Target$25.00
Target Upside210.17%
Target Median$25.00
Target Range25.00 - 25.00
Volume101.55K
Avg Volume201.59K
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
30/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
69/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 6.53Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 16 analyst votes · 2026-10-20
75/100
Bullish
Bullish
8
Hold
8
Bearish
0
Price Target
2026-08-14
Low
$25.00
Mean
$25.00
Median
$25.00
High
$25.00
🧾
No insider activity
No recent insider transactions available.